| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF MK-1084 IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB PLUS PLACEBO AS FIRSTLINE TREATMENT OF PARTICIPANTS WITH KRAS G12C-MUTANT, METASTATIC NSCLC WITH PD-L1 TPS ≥50% |
III |
in corso |
NSCLC |
- SC Oncologia Clinica Sperimentale Toraco - Polmonare |
|
STUDIO OSSERVAZIONALE PROSPETTICO SUL RUOLO DELLA SARCOPENIA, MALNUTRIZIONE E QUALITA’ DELLA DIETA SULL’OUTCOME DEI PAZIENTI AFFETTI DA NEOPLASIA UROTELIALE IN TRATTAMENTO MEDICO |
NA |
in corso |
Carcinoma Uroteliale |
SC Oncologia Clinica Sperimentale Uro - Ginecologica - |
|
NEOADJUVANT ABEMACICLIB AND GIREDESTRANT TRIAL IN PATIENTS WITH ER-POSITIVE, HER2-NEGATIVE EARLY BREAST CANCER |
II |
in corso |
Carcinoma mammario |
- SC Oncologia Clinica Sperimentale di Senologia |
|
International Multicenter Real-World Registry for patients with metastatic renal cell carcinoma Meet-URO 33 study (REGAL study) |
NA |
in corso |
carcinoma renale metastatico |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
A PHASE 1B, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE SAFETY, ENGRAFTMENT, AND INITIAL SIGNS OF CLINICAL ACTIVITY OF MB097 IN COMBINATION WITH PEMBROLIZUMAB IN MELANOMA PATIENTS WITH PRIMARY RESISTANCE TO AN ANTI-PD-1-CONTAINING IMMUNOTHERAPY (MELODY-1) |
I |
in corso |
Melanoma |
- SC Oncologia Clinica Sperimentale del Melanoma – Immunoterapia e Terapie Innovative |
